Summary
Philip Morris International Inc. (PM) reported total net revenues of $29.8 billion for the year ended December 31, 2019, a slight increase of 0.6% from 2018. This growth was primarily driven by favorable pricing and increased volume/mix from its Reduced-Risk Products (RRPs), particularly heated tobacco units (HTUs) and IQOS devices in the EU and Russia. Despite a decline in cigarette shipment volume, the company saw a significant 44.2% increase in HTU shipment volume, reaching 59.7 billion units, underscoring the growing importance of its smoke-free portfolio. However, diluted earnings per share (EPS) decreased by 9.3% to $4.61, impacted by substantial one-time charges including asset impairment and exit costs, a Canadian tobacco litigation-related expense, a loss on the deconsolidation of its Canadian subsidiary (RBH), and a Russia excise and VAT audit charge. The company continues to navigate a challenging operating environment characterized by declining cigarette consumption in many markets, increased taxes, and evolving regulations. PMI's strategic focus remains on transforming the tobacco industry towards a smoke-free future by developing and commercializing RRPs. The strong growth in HTU sales, coupled with the FDA's authorization of its Platform 1 product for sale in the U.S. (licensed to Altria), signals progress in this strategic shift, although significant investments in RRP development and commercialization are expected to continue impacting near-term profitability.
Financial Highlights
51 data points| Revenue | $29.80B |
| Cost of Revenue | $10.51B |
| Gross Profit | $19.29B |
| R&D Expenses | $465.00M |
| Operating Income | $10.53B |
| Interest Expense | $796.00M |
| Net Income | $7.18B |
| EPS (Basic) | $4.61 |
| EPS (Diluted) | $4.61 |
| Shares Outstanding (Basic) | 1.55B |
| Shares Outstanding (Diluted) | 1.56B |
Key Highlights
- 1Net revenues increased slightly by 0.6% to $29.8 billion in 2019, driven by favorable pricing and RRP volume.
- 2Shipments of Heated Tobacco Units (HTUs) increased by 44.2% to 59.7 billion units, indicating strong growth in the smoke-free category.
- 3Diluted EPS decreased by 9.3% to $4.61, negatively impacted by significant charges including asset impairment, litigation expenses, and deconsolidation of a subsidiary.
- 4The company continued to invest heavily in Reduced-Risk Products (RRPs), with R&D expenses for RRPs accounting for 98% of total R&D spending in 2019.
- 5Cigarette shipment volume declined by 4.5% to 706.7 billion units.
- 6Total assets grew to $42.88 billion, and long-term debt stood at $26.66 billion at year-end 2019.
- 7The company paid $7.2 billion in dividends in 2019, with an annualized dividend rate of $4.68 per common share.